CA2130100A1 - Signaux d'internalisation par recepteurs - Google Patents

Signaux d'internalisation par recepteurs

Info

Publication number
CA2130100A1
CA2130100A1 CA 2130100 CA2130100A CA2130100A1 CA 2130100 A1 CA2130100 A1 CA 2130100A1 CA 2130100 CA2130100 CA 2130100 CA 2130100 A CA2130100 A CA 2130100A CA 2130100 A1 CA2130100 A1 CA 2130100A1
Authority
CA
Canada
Prior art keywords
present
alanine
residues
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2130100
Other languages
English (en)
Inventor
Ian S. Trowbridge
James F. Collawn
John A. Tainer
Leslie A. Kuhn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Salk Institute for Biological Studies
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2130100A1 publication Critical patent/CA2130100A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/06—Fusion polypeptide containing a localisation/targetting motif containing a lysosomal/endosomal localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA 2130100 1992-03-03 1993-03-01 Signaux d'internalisation par recepteurs Abandoned CA2130100A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84485292A 1992-03-03 1992-03-03
US844,852 1992-03-03

Publications (1)

Publication Number Publication Date
CA2130100A1 true CA2130100A1 (fr) 1993-09-16

Family

ID=25293794

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2130100 Abandoned CA2130100A1 (fr) 1992-03-03 1993-03-01 Signaux d'internalisation par recepteurs

Country Status (4)

Country Link
EP (1) EP0672132A1 (fr)
JP (1) JPH07508400A (fr)
CA (1) CA2130100A1 (fr)
WO (1) WO1993018185A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
WO1996021416A2 (fr) * 1994-12-30 1996-07-18 Chiron Corporation Procedes et compostions de traitement de tumeurs solides in vivo
ES2137620T3 (es) 1995-06-21 1999-12-16 Tecnogen Scpa Ligandos peptidicos para la region constante de las inmunoglobulinas.
GB0112652D0 (en) 2001-05-24 2001-07-18 Inst Of Molecul & Cell Biology Internalisation of virus into cells
WO2015200357A2 (fr) * 2014-06-23 2015-12-30 Immunomic Therapeutics, Inc. Acides nucléiques pour le traitement d'allergies à l'arachide

Also Published As

Publication number Publication date
EP0672132A1 (fr) 1995-09-20
WO1993018185A1 (fr) 1993-09-16
JPH07508400A (ja) 1995-09-21
EP0672132A4 (fr) 1995-05-23

Similar Documents

Publication Publication Date Title
KR0178022B1 (ko) 단백질-다가양이온 결합체
Siomi et al. A nuclear localization domain in the hnRNP A1 protein.
JPH11510386A (ja) 輸送蛋白質およびそれらの使用
Zaitsev et al. H1 and HMG17 extracted from calf thymus nuclei are efficient DNA carriers in gene transfer
Niidome et al. Gene transfer into hepatoma cells mediated by galactose-modified α-helical peptides
WO1999039742A1 (fr) Fusion de liposome et vehicule d'administration
JP2002525066A (ja) 核酸の特異的な細胞の局在化のための転写法
JPH08504573A (ja) 過剰増殖性細胞の複製阻害方法
Niidome et al. Influence of lipophilic groups in cationic α‐helical peptides on their abilities to bind with DNA and deliver genes into cells
CA2266429A1 (fr) Proteines d'interaction de type herisson et utilisations s'y rapportant
CA2130100A1 (fr) Signaux d'internalisation par recepteurs
WO1999042593A1 (fr) Compositions et procedes servant a sensibiliser et a inhiber la croissance de cellules cancereuses humaines
CA2390104C (fr) Procede de transfert de substances moleculaires au moyen de proteines procaryotiques liant des acides nucleiques
EA006874B1 (ru) Полипептид, обладающий активностью rap [белка, ассоциированного с rip (взаимодействующим с рецептором белком)], кодирующая его последовательность днк и способы их получения и использования
Peränen et al. Expression, purification, and properties of Rab8 function in actin cortical skeleton organization and polarized transport
Kubota et al. Effects of chimeric mutants of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex on nucleolar targeting signals
CN114364704B (zh) 修饰的piggybac转座酶多肽、编码其的多核苷酸、引入载体、试剂盒、将靶序列整合到细胞基因组中的方法以及生产细胞的方法
Kilpatrick et al. Effects of deletion of the cytoplasmic domain upon surface expression and membrane stability of a viral envelope glycoprotein.
CA2481399A1 (fr) Peptides, compositions pharmaceutiques contenant ces peptides pour le traitement du cancer
KR19990008319A (ko) 섬유아세포 성장 인자 15
EP0772620B1 (fr) Oligonucleotides anti-messagers et reversion par le recepteur de l'urokinase du phenotype invasif de fibroblastes humains transformes par l'inhibition de l'expression du gene recepteur d'urokinase par oligonucleotides anti-messagers
Dai et al. Construction of an EGF receptor-mediated histone H1 0-based gene delivery system
CA2228378A1 (fr) Adn complementaire de cytidine deaminase utilise comme marqueur positif pouvant etre selectionne pour le transfert de gene, la therapie genique et la synthese de proteine
CA2118373C (fr) Methode d'inversion du phenotype de cellules transformees par le facteur de transcription irf-i
AU747522B2 (en) Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue

Legal Events

Date Code Title Description
FZDE Dead